Lucia Batzu

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Nirosen Vijiaratnam, Christine Girges, Grace Auld et al. · The Lancet · 2025 · 121 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases

Sara Mariotto, Alberto Gajofatto, Lucia Batzu et al. · Neurology · 2019 · 111 citations

Life Sciences, Neurology, Neuroscience +17

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease

Lucia Batzu, Silvia Rota, Abdul Hye et al. · npj Parkinson s Disease · 2022 · 69 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs

Katarina Rukavina, Lucia Batzu, Alexandra Boogers et al. · Expert Review of Neurotherapeutics · 2021 · 41 citations · Full text

Medicine, Neurology, Neuroscience +16

Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease

Lucia Batzu, Eric Westman, Joana B. Pereira · Neurobiology of Aging · 2019 · 30 citations · Full text

Life Sciences, Neurology, Neuroscience +10